IL1B and ischemic stroke: SYK inhibitor R406 significantly deactivated NLRP3, Caspase-1, and GSDMD-N signaling; reduced the concentration of IL-1β; and attenuated GSDMD-N induced membrane pores in mice with ischemic stroke [39].